Dasatinib and FLAG-IDA Is an Effective Therapy for Initial Myeloid Blast Crisis but Involves a High Risk of Opportunistic Infections

Blast crisis (BC) continues to be the major challenge in the treatment of chronic myeloid leukemia. Best results have been observed in a few patients who were successfully transplanted after returning to chronic phase. Recent studies focus on the combination of chemotherapy with imatinib, but result...

Descripción completa

Detalles Bibliográficos
Autores principales: Labrador, Jorge, Hermida, Gerardo J., Alvarez, Rodolfo, Anso, Victor, de Vicente, Pilar, Goñi, Mercedes, Gonzalez-Lopez, Tomas Jose
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7673920/
https://www.ncbi.nlm.nih.gov/pubmed/33224541
http://dx.doi.org/10.1155/2020/8867461

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7673920/
https://www.ncbi.nlm.nih.gov/pubmed/33224541
http://dx.doi.org/10.1155/2020/8867461

Ejemplares similares